Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma in Situ × Early Intervention, Educational × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 8 Breast Neoplasms 6 Prostatic Neoplasms 5 Lung Neoplasms 5 Papillomavirus Infections 3 Neoplasm Metastasis 3 Lymphoma 3 Triple Negative Breast Neoplasms 2 Skin Carcinoma 2 Obesity-Related Malignant Neoplasm 2 Neoplasms 2 Hematologic Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Ovarian Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Hematopoietic and Lymphatic System Neoplasm 1 Glioblastoma 1 Genital Neoplasms, Female 1 Financial Stress 1 Endometrial Neoplasms 1 Diabetes Mellitus 1

Interventions

dodecyl maltoside 2 Magnetic Resonance Imaging 2 Electrocardiography 2 Diphenhydramine 2 Acetaminophen 2 fludarabine phosphate 1 fludarabine 1 durvalumab 1 cemiplimab 1 aldesleukin 1 Tomography, X-Ray Computed 1 Respiratory Function Tests 1 Prochlorperazine 1 Positron-Emission Tomography 1 Ondansetron 1 O(6)-codeine methyl ether 1 Meperidine 1 Loperamide 1 Interleukin-2 1 Innovar 1 Indomethacin 1 Hydroxyzine 1 Histamine Antagonists 1 Granisetron 1 Droperidol 1 Doxylamine 1 Docetaxel 1 Diphenoxylate 1 Cystoscopy 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡